Globally, some 71 million people are chronically infected with hepatitis C virus (HCV).
Marginalized populations, particularly people who inject drugs (PWID), have low testing …

Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Background & Aims Prisons are key venues for scaling-up hepatitis C virus (HCV) testing
and treatment. Complex clinical pathways and frequent movements of people in prison …

Finding new ways to increase access to hepatitis C (HCV) treatment is integral to reducing
liver diseaserelated deaths and achieving HCV elimination in the Asia-Pacific …

Abstract Background In England, opt-out dry blood spot prison screening for HIV, hepatitis B
and hepatitis C (HCV) has been introduced to scale-up access to care. Recent advances in …

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO)
set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain …

Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have delivered high
response rates (> 95%) and simplified the management of HCV treatment, permitting non …

Background HCV infection among vulnerable populations is currently a major issue for HCV
elimination program. Incarcerated people and people who inject drugs (PWIDs) are key …

Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …